MEDLUMICS IRELAND LIMITED

Overview

MedLumics Ireland Limited, registered with CRO 596658, operates in the medical technology sector. The company, founded in 2009, initially focused on dermatological applications before shifting in 2014 to cardiac health, where it develops biophotonics-based solutions for cardiac care. Its flagship product, the AblaView® Unipolar Hybrid System, is designed to improve real-time visualization of heart tissue during ablation procedures, particularly for atrial fibrillation treatment. The company emphasizes enhancing precision, safety, and efficiency in cardiac procedures, aiming to reduce recurrence rates and improve patient outcomes. It has a strong patent portfolio and operates from Madrid, Spain, with a dedicated laboratory and a network of scientific and clinical partners. The business is positioned to expand beyond atrial fibrillation to other cardiac catheterization applications. The name suggests a focus on medical innovation and healthcare technology, with operations and development rooted in Spain. Beyond registry-level identification, no further business details are publicly captured.

Location & registered address

6Th Floor

2 Grand Canal Square Dublin 2

Dublin 2

Dublin

Dublin 2

Dublin

Ireland

Industry classification

NACE Rev. 2 — 72.19

→ All NACE 72.19 companies in Ireland · In Dublin